You are here:

  1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Diabetes and other endocrinal, nutritional and metabolic conditions
  5. Diabetes

Dapagliflozin in triple therapy for treating type 2 diabetes

  • Technology appraisal guidance
  • Reference number: TA418
  • Published:  23 November 2016
  • Guidance
  • Tools and resources
  • Information for the public
  • History

Tools and resources

Tools to help you put the guidance into practice.

Guidance into practice

  • About the Into practice guide

  • Practical steps to improving the quality of care and services using NICE guidance

Back to top